The Ultimate Resource for Pharmaceutical SOPs and Best Practices
The purpose of this SOP is to establish the procedure for conducting hygroscopicity testing of capsule fill materials. The objective is to evaluate the moisture absorption properties of the materials to ensure stability, prevent clumping, and maintain consistency in capsule fill weights during manufacturing and storage.
Click to read the full article.
The purpose of this SOP is to define the procedure for granulation development for hard gelatin capsules. Granulation ensures that the active pharmaceutical ingredient (API) and excipients are uniformly distributed in the fill material, improving the flowability, compressibility, and overall quality of the capsule content.
Click to read the full article.
The purpose of this SOP is to define the procedure for particle size reduction of capsule fill materials to ensure uniformity in particle size distribution, improve flow properties, and enhance the overall quality of the final capsule product.
Click to read the full article.
The purpose of this SOP is to define the procedure for particle size reduction of fill materials used in capsule formulations. The objective is to achieve the desired particle size distribution to ensure uniformity in capsule filling, dissolution, and bioavailability.
Click to read the full article.
The purpose of this SOP is to outline the procedure for selecting plasticizers for soft gelatin capsule shells to achieve the required flexibility, stability, and performance characteristics for the final product.
Click to read the full article.
The purpose of this SOP is to establish the procedure for selecting plasticizers for soft gelatin capsule shells, ensuring that the selected plasticizer enhances the flexibility, stability, and overall quality of the capsule shells.
Click to read the full article.
The purpose of this SOP is to outline the procedure for conducting rheological studies on gelatin to determine its flow properties, which are critical for capsule shell formulation, texture, and performance during manufacturing.
Click to read the full article.
The purpose of this SOP is to outline the procedure for conducting bioequivalence studies for capsule dosage forms to demonstrate that a generic formulation performs similarly to the reference (innovator) product in terms of bioavailability and therapeutic effectiveness.
Click to read the full article.
The purpose of this SOP is to establish the procedure for optimizing the fill volume in capsule manufacturing, ensuring accurate and consistent dosage while minimizing material waste and production errors.
Click to read the full article.
This SOP outlines the procedure for developing prototype capsule dosage forms, ensuring that they meet the desired pharmacological properties, stability, and manufacturability criteria for further scale-up and clinical trials.
Click to read the full article.